ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The disruption of Smo, a key component in the Hh signaling pathway, resulted in the suppression of leukemic stem cells expressing BCR-ABL and led to an extended survival period in a mouse model of chronic myeloid leukemia research.292